|
|
|
Fiscal Period: April
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Capitalization1 |
113 741 | 108 606 | 119 108 | 130 840 | 176 490 | 141 985 | - | - |
| Enterprise Value (EV)1 |
133 474 | 123 136 | 134 584 | 151 497 | 199 286 | 163 672 | 160 707 | 158 855 |
| P/E ratio |
28,8x | 35,3x | 26,0x | 27,6x | 49,2x | 26,0x | 21,6x | 19,7x |
| Yield |
2,07% | 2,30% | 2,25% | 2,38% | 1,77% | 2,37% | 2,53% | 2,72% |
| Capitalization / Revenue |
3,83x | 3,63x | 3,90x | 4,53x | 5,86x | 4,39x | 4,17x | 3,96x |
| EV / Revenue |
4,49x | 4,11x | 4,40x | 5,24x | 6,62x | 5,06x | 4,72x | 4,43x |
| EV / EBITDA |
14,4x | 13,4x | 13,8x | 17,9x | 24,6x | 16,4x | 14,9x | 13,7x |
| Price to Book |
2,26x | 2,14x | 2,39x | 2,58x | 3,42x | 2,70x | 2,63x | 2,53x |
| Nbr of stocks (in thousands) |
1 368 885 | 1 355 373 | 1 341 151 | 1 340 166 | 1 348 073 | 1 344 558 | - | - |
| Reference price (USD) |
83,1 | 80,1 | 88,8 | 97,6 | 131 | 106 | 106 | 106 |
| Announcement Date |
05/25/2017 | 05/24/2018 | 05/23/2019 | 05/21/2020 | 05/27/2021 | - | - | - |
1 USD in Million |
|
|
| Income Statement Evolution (Annual data) |
|
|
Fiscal Period: April
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Net sales1 |
29 710 | 29 953 | 30 557 | 28 913 | 30 117 | 32 319 | 34 066 | 35 868 |
| EBITDA1 |
9 288 | 9 173 | 9 767 | 8 472 | 8 096 | 9 989 | 10 771 | 11 557 |
| Operating profit (EBIT)1 |
8 351 | 8 352 | 8 872 | 7 565 | 7 177 | 9 113 | 9 837 | 10 563 |
| Operating Margin |
28,1% | 27,9% | 29,0% | 26,2% | 23,8% | 28,2% | 28,9% | 29,5% |
| Pre-Tax Profit (EBT)1 |
4 602 | 5 675 | 5 197 | 4 055 | 3 895 | 6 307 | 7 816 | 8 487 |
| Net income1 |
4 028 | 3 104 | 4 631 | 4 789 | 3 606 | 5 521 | 6 608 | 7 159 |
| Net margin |
13,6% | 10,4% | 15,2% | 16,6% | 12,0% | 17,1% | 19,4% | 20,0% |
| EPS2 |
2,89 | 2,27 | 3,41 | 3,54 | 2,66 | 4,06 | 4,89 | 5,37 |
| Dividend per Share2 |
1,72 | 1,84 | 2,00 | 2,32 | 2,32 | 2,50 | 2,67 | 2,88 |
| Announcement Date |
05/25/2017 | 05/24/2018 | 05/23/2019 | 05/21/2020 | 05/27/2021 | - | - | - |
1 USD in Million 2 USD |
|
|
| Income Statement Evolution (Quarterly data) |
|
|
Fiscal Period: April
|
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
2023 Q1 |
2023 Q2 |
2023 Q3 |
| Net sales1 |
7 493 | 7 706 | 7 717 | 5 998 | 6 507 | 7 647 | 7 775 | 8 188 | 7 987 | 7 847 | 7 949 | 8 552 | 8 320 | 8 310 | 8 466 |
| EBITDA1 |
2 333 | 2 395 | 2 548 | 1 196 | 1 305 | 1 930 | 2 293 | 2 571 | 2 493 | 2 361 | 2 443 | 2 760 | 2 554 | 2 594 | 2 673 |
| Operating profit (EBIT)1 |
2 116 | 2 165 | 2 321 | 963 | 1 076 | 1 702 | 2 068 | 2 333 | 2 258 | 2 116 | 2 200 | 2 520 | 2 344 | 2 352 | 2 449 |
| Operating Margin |
28,2% | 28,1% | 30,1% | 16,1% | 16,5% | 22,3% | 26,6% | 28,5% | 28,3% | 27,0% | 27,7% | 29,5% | 28,2% | 28,3% | 28,9% |
| Pre-Tax Profit (EBT)1 |
977 | - | 1 579 | 206 | - | - | - | - | 833 | - | 1 963 | 2 272 | - | - | - |
| Net income1 |
864 | 1 364 | 1 915 | 646 | 487 | 489 | 1 270 | 1 361 | 763 | 1 311 | 1 516 | 1 807 | 1 608 | 1 616 | 1 680 |
| Net margin |
11,5% | 17,7% | 24,8% | 10,8% | 7,48% | 6,39% | 16,3% | 16,6% | 9,55% | 16,7% | 19,1% | 21,1% | 19,3% | 19,4% | 19,8% |
| EPS2 |
0,64 | 1,01 | 1,42 | 0,48 | 0,36 | 0,36 | 0,94 | 1,00 | 0,56 | 0,97 | 1,12 | 1,33 | 1,19 | 1,19 | 1,25 |
| Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date |
08/20/2019 | 11/19/2019 | 02/18/2020 | 05/21/2020 | 08/25/2020 | 11/24/2020 | 02/23/2021 | 05/27/2021 | 08/24/2021 | 11/23/2021 | - | - | - | - | - |
1 USD in Million 2 USD |
|
|
|
|
|
Fiscal Period: April
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Net Debt1 |
19 733 | 14 530 | 15 476 | 20 657 | 22 796 | 21 686 | 18 721 | 16 870 |
| Net Cash position1 |
- | - | - | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
2,12x | 1,58x | 1,58x | 2,44x | 2,82x | 2,17x | 1,74x | 1,46x |
| Free Cash Flow1 |
5 600 | 4 700 | 5 873 | 6 021 | 4 885 | 6 139 | 7 336 | 7 831 |
| ROE (Net Profit / Equities) |
12,5% | 12,9% | 14,1% | 12,3% | 11,8% | 14,5% | 15,7% | 16,5% |
| Shareholders' equity1 |
32 236 | 23 988 | 32 928 | 38 903 | 30 675 | 38 047 | 42 202 | 43 304 |
| ROA (Net Profit / Asset) |
4,04% | 6,83% | 7,83% | 6,88% | 6,54% | 7,06% | 7,72% | 8,50% |
| Assets1 |
99 730 | 45 455 | 59 149 | 69 598 | 55 178 | 78 154 | 85 622 | 84 239 |
| Book Value Per Share2 |
36,7 | 37,4 | 37,2 | 37,8 | 38,2 | 39,2 | 40,2 | 41,7 |
| Cash Flow per Share2 |
4,95 | 3,42 | 5,16 | 5,35 | 4,61 | 5,39 | 6,54 | 7,08 |
| Capex1 |
1 254 | 1 068 | 1 134 | 1 213 | 1 355 | 1 400 | 1 456 | 1 539 |
| Capex / Sales |
4,22% | 3,57% | 3,71% | 4,20% | 4,50% | 4,33% | 4,28% | 4,29% |
| Announcement Date |
05/25/2017 | 05/24/2018 | 05/23/2019 | 05/21/2020 | 05/27/2021 | - | - | - |
1 USD in Million 2 USD |
|
|
|
|
|
Automakers, medical device firms ask Biden for U.S. chip factory subsidies |
| Capitalization (USD) |
141 985 301 990 |
| Net sales (USD) |
30 117 000 000 |
| Number of employees |
90 000 |
| Sales / Employee (USD) |
334 633 |
| Free-Float |
99,8% |
| Free-Float capitalization (USD) |
141 652 851 648 |
| Avg. Exchange 20 sessions (USD) |
703 326 909 |
| Average Daily Capital Traded |
0,50% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous period
